Biomarkers (e.g. estrogen receptor status in breast cancer, epidermal growth factor receptor (EGFR) status in lung adenocarcinoma, mismatch repair in colorectal cancer) are frequently reported by pathologists that do not finalize the case. The gene discussed is ESR1; the disease is breast carcinoma.